Improving survival for children with brain tumors using targeted therapies.
Pediatric brain tumors: Improving survival through integration of clinical molecular diagnostics and biologically targeted therapies into clinical trials
This study is looking to improve the chances of survival for kids with brain tumors by using new treatments that are specially designed based on the unique biology of their tumors, while also working to minimize the side effects of standard cancer treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Seattle Children's Hospital NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11046518 on NIH RePORTER |
What this research studies
This research aims to enhance the survival rates of children diagnosed with central nervous system tumors by integrating clinical molecular diagnostics with biologically targeted therapies in clinical trials. The approach involves developing novel treatments based on a deep understanding of the molecular mechanisms driving these tumors. By collaborating with national and international clinical trial networks, the research seeks to create a framework for sharing genomic data and facilitating innovative treatment options. This initiative is particularly focused on reducing the long-term side effects associated with traditional cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who have been diagnosed with central nervous system tumors.
Not a fit: Patients with brain tumors who are older than 11 years or those with non-CNS tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and reduced treatment-related toxicity for children with brain tumors.
How similar studies have performed: Previous research has shown promising results in using targeted therapies for pediatric cancers, indicating a potential for success in this novel approach.
Where this research is happening
Seattle, United States
- Seattle Children's Hospital — Seattle, United States (Active)
Researchers
- Principal investigator: Leary, Sarah Elisabeth Sherr — Seattle Children's Hospital
- Study coordinator: Leary, Sarah Elisabeth Sherr
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.